This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

GLORIA-AF Registry Program - Second and Third Phases

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim
ClinicalTrials.gov Identifier:
NCT01468701
First received: October 28, 2011
Last updated: March 27, 2017
Last verified: March 2017
  Purpose
In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purposes the study is divided into two protocol numbers: 1160.129 for all non-EU (European Union) and non-EEA (European Economic Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.

Condition
Stroke Atrial Fibrillation

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)

Resource links provided by NLM:


Further study details as provided by Boehringer Ingelheim:

Primary Outcome Measures:
  • Myocardial infarction [ Time Frame: up to 3 years ]
  • Life-threatening bleeding events [ Time Frame: up to 3 years ]
  • All cause death [ Time Frame: up to 3 years ]
  • Vascular death [ Time Frame: up to 3 years ]
  • composite endpoint: Stroke, systemic embolism, myocardial infarction and vascular death (vascular composite endpoint) [ Time Frame: up to 3 years ]
  • Stroke (hemorrhagic and ischemic, uncertain classification) [ Time Frame: up to 3 years ]
  • Transient Ischemic attack (TIA) [ Time Frame: up to 3 years ]
  • Systemic embolism [ Time Frame: up to 3 years ]
  • Pulmonary embolism [ Time Frame: up to 3 years ]
  • composite endpoint: stroke, systemic embolism, myocardial infarction, life-threatening bleeding events and vascular death [ Time Frame: up to 3 years ]
  • Major bleeding events (including life-threatening bleeding events) [ Time Frame: up to 3 years ]

Estimated Enrollment: 19000
Study Start Date: November 2011
Estimated Study Completion Date: January 2020
Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients with non-valvular AF
Criteria

Inclusion criteria:

  1. Age =>18 years at enrollment
  2. Male or female patient (or legally acceptable representative) willing and able to provide written informed consent
  3. Patient newly diagnosed (< 3 months prior to baseline visit) with non-valvular AF and at risk for stroke.

Other inclusion criteria apply.

Exclusion criteria:

  1. Presence of any mechanical heart valve, or valve disease that is expected to require valve replacement intervention;
  2. Patients who have received more than 60 days of vitamin K antagonist (VKA) treatment in their lifetime;
  3. AF with a generally reversible cause;
  4. Patients with a medical condition other than atrial fibrillation for which chronic use of an oral anticoagulant (for example, a VKA) is indicated Other exclusion criteria apply
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01468701

  Hide Study Locations
Locations
United States, Alabama
Boehringer Ingelheim Investigational Site
Mobile, Alabama, United States
Boehringer Ingelheim Investigational Site
Northport, Alabama, United States
Boehringer Ingelheim Investigational Site
Scottsboro, Alabama, United States
United States, Alaska
Boehringer Ingelheim Investigational Site
Anchorage, Alaska, United States
United States, Arizona
Boehringer Ingelheim Investigational Site
Glendale, Arizona, United States
Boehringer Ingelheim Investigational Site
Hot Springs, Arizona, United States
Boehringer Ingelheim Investigational Site
Lake Havasu City, Arizona, United States
United States, Arkansas
Boehringer Ingelheim Investigational Site
Fort Smith, Arkansas, United States
Boehringer Ingelheim Investigational Site
Hot Springs, Arkansas, United States
Boehringer Ingelheim Investigational Site
Little Rock, Arkansas, United States
United States, California
Boehringer Ingelheim Investigational Site
Encinitas, California, United States
Boehringer Ingelheim Investigational Site
Fountain Valley, California, United States
Boehringer Ingelheim Investigational Site
Fresno, California, United States
Boehringer Ingelheim Investigational Site
Hawaiian Gardens, California, United States
Boehringer Ingelheim Investigational Site
La Jolla, California, United States
Boehringer Ingelheim Investigational Site
La Mesa, California, United States
Boehringer Ingelheim Investigational Site
Los Alamitos, California, United States
Boehringer Ingelheim Investigational Site
Los Angeles, California, United States
Boehringer Ingelheim Investigational Site
Northridge, California, United States
Boehringer Ingelheim Investigational Site
Palo Alto, California, United States
Boehringer Ingelheim Investigational Site
Rancho Mirage, California, United States
Boehringer Ingelheim Investigational Site
San Diego, California, United States
Boehringer Ingelheim Investigational Site
Santa Ana, California, United States
Boehringer Ingelheim Investigational Site
Stockton, California, United States
Boehringer Ingelheim Investigational Site
Temecula, California, United States
Boehringer Ingelheim Investigational Site
Torrance, California, United States
Boehringer Ingelheim Investigational Site
Ventura, California, United States
Boehringer Ingelheim Investigational Site
Visalia, California, United States
United States, Colorado
Boehringer Ingelheim Investigational Site
Aurora, Colorado, United States
Boehringer Ingelheim Investigational Site
Colorado Springs, Colorado, United States
Boehringer Ingelheim Investigational Site
Denver, Colorado, United States
Boehringer Ingelheim Investigational Site
Littleton, Colorado, United States
United States, Connecticut
Boehringer Ingelheim Investigational Site
Bridgeport, Connecticut, United States
Boehringer Ingelheim Investigational Site
Norwalk, Connecticut, United States
Boehringer Ingelheim Investigational Site
Shelton, Connecticut, United States
United States, Delaware
Boehringer Ingelheim Investigational Site
Newark, Delaware, United States
United States, District of Columbia
Boehringer Ingelheim Investigational Site
Washington, District of Columbia, United States
United States, Florida
Boehringer Ingelheim Investigational Site
Aventura, Florida, United States
Boehringer Ingelheim Investigational Site
Brandon, Florida, United States
Boehringer Ingelheim Investigational Site
Clearwater, Florida, United States
Boehringer Ingelheim Investigational Site
Delray Beach, Florida, United States
Boehringer Ingelheim Investigational Site
Doral, Florida, United States
Boehringer Ingelheim Investigational Site
Gainesville, Florida, United States
Boehringer Ingelheim Investigational Site
Hialeah, Florida, United States
Boehringer Ingelheim Investigational Site
Hollywood, Florida, United States
Boehringer Ingelheim Investigational Site
Jacksonville, Florida, United States
Boehringer Ingelheim Investigational Site
Jupiter, Florida, United States
Boehringer Ingelheim Investigational Site
Lakeland, Florida, United States
Boehringer Ingelheim Investigational Site
Miami, Florida, United States
Boehringer Ingelheim Investigational Site
Miramar Beach, Florida, United States
Boehringer Ingelheim Investigational Site
Naples, Florida, United States
Boehringer Ingelheim Investigational Site
New Smyrna Beach, Florida, United States
Boehringer Ingelheim Investigational Site
Oakland Park, Florida, United States
Boehringer Ingelheim Investigational Site
Orlando, Florida, United States
Boehringer Ingelheim Investigational Site
Pembrooke Pines, Florida, United States
Boehringer Ingelheim Investigational Site
Pensacola, Florida, United States
Boehringer Ingelheim Investigational Site
Port Charlotte, Florida, United States
Boehringer Ingelheim Investigational Site
Rockledge, Florida, United States
Boehringer Ingelheim Investigational Site
Saint Petersburg, Florida, United States
Boehringer Ingelheim Investigational Site
Sarasota, Florida, United States
Boehringer Ingelheim Investigational Site
Seminole, Florida, United States
Boehringer Ingelheim Investigational Site
St. Petersburg, Florida, United States
Boehringer Ingelheim Investigational Site
Tallahassee, Florida, United States
Boehringer Ingelheim Investigational Site
Tampa, Florida, United States
Boehringer Ingelheim Investigational Site
Vero Beach, Florida, United States
Boehringer Ingelheim Investigational Site
Wellington, Florida, United States
United States, Georgia
Boehringer Ingelheim Investigational Site
Atlanta, Georgia, United States
Boehringer Ingelheim Investigational Site
Cumming, Georgia, United States
Boehringer Ingelheim Investigational Site
Decatur, Georgia, United States
Boehringer Ingelheim Investigational Site
Macon, Georgia, United States
United States, Idaho
Boehringer Ingelheim Investigational Site
Coeurd'Alene, Idaho, United States
United States, Illinois
Boehringer Ingelheim Investigational Site
Arlington Heights, Illinois, United States
Boehringer Ingelheim Investigational Site
Belleville, Illinois, United States
Boehringer Ingelheim Investigational Site
Carbondale, Illinois, United States
Boehringer Ingelheim Investigational Site
Chicago, Illinois, United States
Boehringer Ingelheim Investigational Site
Hinsdale, Illinois, United States
Boehringer Ingelheim Investigational Site
Melrose Park, Illinois, United States
Boehringer Ingelheim Investigational Site
Morton, Illinois, United States
Boehringer Ingelheim Investigational Site
Rock Island, Illinois, United States
Boehringer Ingelheim Investigational Site
Winfield, Illinois, United States
United States, Indiana
Boehringer Ingelheim Investigational Site
Brownsburg, Indiana, United States
Boehringer Ingelheim Investigational Site
Fort Wayne, Indiana, United States
Boehringer Ingelheim Investigational Site
Indianapolis, Indiana, United States
Boehringer Ingelheim Investigational Site
LaPorte, Indiana, United States
Boehringer Ingelheim Investigational Site
Munster, Indiana, United States
Boehringer Ingelheim Investigational Site
South Bend, Indiana, United States
United States, Iowa
Boehringer Ingelheim Investigational Site
Ames, Iowa, United States
Boehringer Ingelheim Investigational Site
Iowa City, Iowa, United States
Boehringer Ingelheim Investigational Site
Waterloo, Iowa, United States
Boehringer Ingelheim Investigational Site
West Des Moines, Iowa, United States
United States, Kansas
Boehringer Ingelheim Investigational Site
Overland Park, Kansas, United States
United States, Kentucky
Boehringer Ingelheim Investigational Site
Elizabeth, Kentucky, United States
Boehringer Ingelheim Investigational Site
Louisville, Kentucky, United States
Boehringer Ingelheim Investigational Site
Madisonville, Kentucky, United States
Boehringer Ingelheim Investigational Site
Mount Sterling, Kentucky, United States
Boehringer Ingelheim Investigational Site
Owensboro, Kentucky, United States
United States, Louisiana
Boehringer Ingelheim Investigational Site
Alexandria, Louisiana, United States
Boehringer Ingelheim Investigational Site
Baton Rouge, Louisiana, United States
Boehringer Ingelheim Investigational Site
Bossier City, Louisiana, United States
Boehringer Ingelheim Investigational Site
Hammond, Louisiana, United States
Boehringer Ingelheim Investigational Site
Kenner, Louisiana, United States
Boehringer Ingelheim Investigational Site
Lake Charles, Louisiana, United States
Boehringer Ingelheim Investigational Site
New Orleans, Louisiana, United States
Boehringer Ingelheim Investigational Site
Shreveport, Louisiana, United States
Boehringer Ingelheim Investigational Site
Slidell, Louisiana, United States
United States, Maine
Boehringer Ingelheim Investigational Site
Biddeford, Maine, United States
United States, Maryland
Boehringer Ingelheim Investigational Site
Annapolis, Maryland, United States
Boehringer Ingelheim Investigational Site
Baltimore, Maryland, United States
Boehringer Ingelheim Investigational Site
Clinton, Maryland, United States
Boehringer Ingelheim Investigational Site
Columbia, Maryland, United States
Boehringer Ingelheim Investigational Site
Salisbury, Maryland, United States
Boehringer Ingelheim Investigational Site
Towson, Maryland, United States
United States, Massachusetts
Boehringer Ingelheim Investigational Site
Ayer, Massachusetts, United States
Boehringer Ingelheim Investigational Site
Brighton, Massachusetts, United States
Boehringer Ingelheim Investigational Site
Fall River, Massachusetts, United States
Boehringer Ingelheim Investigational Site
Newton, Massachusetts, United States
United States, Michigan
Boehringer Ingelheim Investigational Site
Alpena, Michigan, United States
Boehringer Ingelheim Investigational Site
Bay City, Michigan, United States
Boehringer Ingelheim Investigational Site
Detroit, Michigan, United States
Boehringer Ingelheim Investigational Site
Erie, Michigan, United States
Boehringer Ingelheim Investigational Site
Flint, Michigan, United States
Boehringer Ingelheim Investigational Site
Grand Blanc, Michigan, United States
Boehringer Ingelheim Investigational Site
Lansing, Michigan, United States
Boehringer Ingelheim Investigational Site
Marquette, Michigan, United States
Boehringer Ingelheim Investigational Site
Mount Clemens, Michigan, United States
Boehringer Ingelheim Investigational Site
Niles, Michigan, United States
Boehringer Ingelheim Investigational Site
Novi, Michigan, United States
Boehringer Ingelheim Investigational Site
Saginaw, Michigan, United States
United States, Minnesota
Boehringer Ingelheim Investigational Site
Duluth, Minnesota, United States
Boehringer Ingelheim Investigational Site
Minneapolis, Minnesota, United States
Boehringer Ingelheim Investigational Site
St Cloud, Minnesota, United States
Boehringer Ingelheim Investigational Site
St. Paul, Minnesota, United States
United States, Mississippi
Boehringer Ingelheim Investigational Site
Biloxi, Mississippi, United States
Boehringer Ingelheim Investigational Site
Jackson, Mississippi, United States
United States, Missouri
Boehringer Ingelheim Investigational Site
Kansas City, Missouri, United States
Boehringer Ingelheim Investigational Site
St Joseph, Missouri, United States
Boehringer Ingelheim Investigational Site
St Louis, Missouri, United States
Boehringer Ingelheim Investigational Site
St. Louis, Missouri, United States
United States, Montana
Boehringer Ingelheim Investigational Site
Kalispell, Montana, United States
United States, Nebraska
Boehringer Ingelheim Investigational Site
Omaha, Nebraska, United States
Boehringer Ingelheim Investigational Site
Papillion, Nebraska, United States
United States, Nevada
Boehringer Ingelheim Investigational Site
Reno, Nevada, United States
United States, New Jersey
Boehringer Ingelheim Investigational Site
Bridgewater, New Jersey, United States
Boehringer Ingelheim Investigational Site
Camden, New Jersey, United States
Boehringer Ingelheim Investigational Site
Eatontown, New Jersey, United States
Boehringer Ingelheim Investigational Site
Hackensack, New Jersey, United States
Boehringer Ingelheim Investigational Site
Haddon Heights, New Jersey, United States
Boehringer Ingelheim Investigational Site
Linden, New Jersey, United States
Boehringer Ingelheim Investigational Site
Manalapan, New Jersey, United States
Boehringer Ingelheim Investigational Site
Neptune, New Jersey, United States
Boehringer Ingelheim Investigational Site
New Brunswick, New Jersey, United States
Boehringer Ingelheim Investigational Site
Paterson, New Jersey, United States
Boehringer Ingelheim Investigational Site
Ridgewood, New Jersey, United States
Boehringer Ingelheim Investigational Site
Somerset, New Jersey, United States
Boehringer Ingelheim Investigational Site
South Plainfield, New Jersey, United States
Boehringer Ingelheim Investigational Site
Voorhees, New Jersey, United States
Boehringer Ingelheim Investigational Site
West Orange, New Jersey, United States
United States, New Mexico
Boehringer Ingelheim Investigational Site
Albuquerque, New Mexico, United States
United States, New York
Boehringer Ingelheim Investigational Site
Albany, New York, United States
Boehringer Ingelheim Investigational Site
Bronx, New York, United States
Boehringer Ingelheim Investigational Site
Brooklyn, New York, United States
Boehringer Ingelheim Investigational Site
Camillus, New York, United States
Boehringer Ingelheim Investigational Site
Cooperstown, New York, United States
Boehringer Ingelheim Investigational Site
Flushing, New York, United States
Boehringer Ingelheim Investigational Site
Johnson City, New York, United States
Boehringer Ingelheim Investigational Site
Mineola, New York, United States
Boehringer Ingelheim Investigational Site
New York, New York, United States
Boehringer Ingelheim Investigational Site
Saratoga Springs, New York, United States
Boehringer Ingelheim Investigational Site
Stony Brook, New York, United States
Boehringer Ingelheim Investigational Site
Syracuse, New York, United States
Boehringer Ingelheim Investigational Site
Westfield, New York, United States
Boehringer Ingelheim Investigational Site
Williamsville, New York, United States
United States, North Carolina
Boehringer Ingelheim Investigational Site
Burlington, North Carolina, United States
Boehringer Ingelheim Investigational Site
Hickory, North Carolina, United States
Boehringer Ingelheim Investigational Site
High Point, North Carolina, United States
Boehringer Ingelheim Investigational Site
Jacksonville, North Carolina, United States
Boehringer Ingelheim Investigational Site
Kannapolis, North Carolina, United States
Boehringer Ingelheim Investigational Site
Lenoir, North Carolina, United States
Boehringer Ingelheim Investigational Site
Pinehurst, North Carolina, United States
Boehringer Ingelheim Investigational Site
Raleigh, North Carolina, United States
Boehringer Ingelheim Investigational Site
Wilson, North Carolina, United States
United States, North Dakota
Boehringer Ingelheim Investigational Site
Fargo, North Dakota, United States
Boehringer Ingelheim Investigational Site
Minot, North Dakota, United States
United States, Ohio
Boehringer Ingelheim Investigational Site
Canton, Ohio, United States
Boehringer Ingelheim Investigational Site
Cincinnati, Ohio, United States
Boehringer Ingelheim Investigational Site
Cleveland, Ohio, United States
Boehringer Ingelheim Investigational Site
Fairfield, Ohio, United States
Boehringer Ingelheim Investigational Site
Fairview Park, Ohio, United States
Boehringer Ingelheim Investigational Site
Hudson, Ohio, United States
Boehringer Ingelheim Investigational Site
Kettering, Ohio, United States
Boehringer Ingelheim Investigational Site
Marion, Ohio, United States
Boehringer Ingelheim Investigational Site
Miamisburg, Ohio, United States
Boehringer Ingelheim Investigational Site
Springfield, Ohio, United States
Boehringer Ingelheim Investigational Site
Toledo, Ohio, United States
Boehringer Ingelheim Investigational Site
Willoughby, Ohio, United States
Boehringer Ingelheim Investigational Site
Youngstown, Ohio, United States
United States, Oklahoma
Boehringer Ingelheim Investigational Site
Oklahoma City, Oklahoma, United States
United States, Oregon
Boehringer Ingelheim Investigational Site
Corvallis, Oregon, United States
Boehringer Ingelheim Investigational Site
Portland, Oregon, United States
Boehringer Ingelheim Investigational Site
Springfield, Oregon, United States
United States, Pennsylvania
Boehringer Ingelheim Investigational Site
Abington, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Camp Hill, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Carnegie, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Chambersburg, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Doylestown, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Ephrata, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Harleysville, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Jersey Shore, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Lansdale, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Philadelphia, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Pittsburgh, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Sellersville, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Warminster, Pennsylvania, United States
Boehringer Ingelheim Investigational Site
Yardley, Pennsylvania, United States
United States, Rhode Island
Boehringer Ingelheim Investigational Site
Pawtucket, Rhode Island, United States
Boehringer Ingelheim Investigational Site
Wakefield, Rhode Island, United States
United States, South Carolina
Boehringer Ingelheim Investigational Site
Anderson, South Carolina, United States
Boehringer Ingelheim Investigational Site
Beaufort, South Carolina, United States
Boehringer Ingelheim Investigational Site
Columbia, South Carolina, United States
Boehringer Ingelheim Investigational Site
Greenwood, South Carolina, United States
Boehringer Ingelheim Investigational Site
Myrtle Beach, South Carolina, United States
United States, South Dakota
Boehringer Ingelheim Investigational Site
Rapid Citty, South Dakota, United States
United States, Tennessee
Boehringer Ingelheim Investigational Site
Chatanooga, Tennessee, United States
Boehringer Ingelheim Investigational Site
Jackson, Tennessee, United States
Boehringer Ingelheim Investigational Site
Johnson City, Tennessee, United States
Boehringer Ingelheim Investigational Site
Knoxville, Tennessee, United States
United States, Texas
Boehringer Ingelheim Investigational Site
Austin, Texas, United States
Boehringer Ingelheim Investigational Site
Beaumont, Texas, United States
Boehringer Ingelheim Investigational Site
Dallas, Texas, United States
Boehringer Ingelheim Investigational Site
Fort Worth, Texas, United States
Boehringer Ingelheim Investigational Site
Grapevine, Texas, United States
Boehringer Ingelheim Investigational Site
Houston, Texas, United States
Boehringer Ingelheim Investigational Site
Humble, Texas, United States
Boehringer Ingelheim Investigational Site
Katy, Texas, United States
Boehringer Ingelheim Investigational Site
Kingwood, Texas, United States
Boehringer Ingelheim Investigational Site
Lubbock, Texas, United States
Boehringer Ingelheim Investigational Site
New Braunfels, Texas, United States
Boehringer Ingelheim Investigational Site
San Antonio, Texas, United States
Boehringer Ingelheim Investigational Site
Sealy, Texas, United States
Boehringer Ingelheim Investigational Site
Seguin, Texas, United States
Boehringer Ingelheim Investigational Site
Sugar Land, Texas, United States
Boehringer Ingelheim Investigational Site
Tyler, Texas, United States
Boehringer Ingelheim Investigational Site
Waco, Texas, United States
Boehringer Ingelheim Investigational Site
Whitney, Texas, United States
United States, Utah
Boehringer Ingelheim Investigational Site
Salt Lake City, Utah, United States
United States, Virginia
Boehringer Ingelheim Investigational Site
Burke, Virginia, United States
Boehringer Ingelheim Investigational Site
Charlottesville, Virginia, United States
Boehringer Ingelheim Investigational Site
Chesapeake, Virginia, United States
Boehringer Ingelheim Investigational Site
Danville, Virginia, United States
Boehringer Ingelheim Investigational Site
Falls Church, Virginia, United States
Boehringer Ingelheim Investigational Site
Fredericksburg, Virginia, United States
Boehringer Ingelheim Investigational Site
Harrisonburg, Virginia, United States
Boehringer Ingelheim Investigational Site
Manassas, Virginia, United States
Boehringer Ingelheim Investigational Site
Midlothian, Virginia, United States
Boehringer Ingelheim Investigational Site
Richmond, Virginia, United States
Boehringer Ingelheim Investigational Site
Roanoke, Virginia, United States
Boehringer Ingelheim Investigational Site
Salem, Virginia, United States
Boehringer Ingelheim Investigational Site
Winchester, Virginia, United States
United States, Washington
Boehringer Ingelheim Investigational Site
Port Orchard, Washington, United States
Boehringer Ingelheim Investigational Site
Seattle, Washington, United States
Boehringer Ingelheim Investigational Site
Tacoma, Washington, United States
Boehringer Ingelheim Investigational Site
Yakima, Washington, United States
United States, West Virginia
Boehringer Ingelheim Investigational Site
Charleston, West Virginia, United States
Boehringer Ingelheim Investigational Site
Huntington, West Virginia, United States
United States, Wisconsin
Boehringer Ingelheim Investigational Site
La Crosse, Wisconsin, United States
Boehringer Ingelheim Investigational Site
Milwaukee, Wisconsin, United States
Boehringer Ingelheim Investigational Site
Waukesha, Wisconsin, United States
Argentina
Boehringer Ingelheim Investigational Site
Buenos Aires, Argentina
Boehringer Ingelheim Investigational Site
Caba, Argentina
Boehringer Ingelheim Investigational Site
Cordoba, Argentina
Boehringer Ingelheim Investigational Site
Corrientes, Argentina
Boehringer Ingelheim Investigational Site
Godoy Cruz, Argentina
Boehringer Ingelheim Investigational Site
Mar del Plata, Argentina
Boehringer Ingelheim Investigational Site
Mendoza, Argentina
Boehringer Ingelheim Investigational Site
Ramos Mejía, Argentina
Boehringer Ingelheim Investigational Site
Rosario, Argentina
Boehringer Ingelheim Investigational Site
San Isidro, Argentina
Boehringer Ingelheim Investigational Site
Santa Fe, Argentina
Boehringer Ingelheim Investigational Site
Temperley, Argentina
Boehringer Ingelheim Investigational Site
Tucuman, Argentina
Boehringer Ingelheim Investigational Site
Tucumán, Argentina
Boehringer Ingelheim Investigational Site
Villa Luro, Argentina
Brazil
Boehringer Ingelheim Investigational Site
Belo Horizonte, Brazil
Boehringer Ingelheim Investigational Site
Blumenau, Brazil
Boehringer Ingelheim Investigational Site
Brasilia, Brazil
Boehringer Ingelheim Investigational Site
Campina Grande do Sul, Brazil
Boehringer Ingelheim Investigational Site
Campinas, Brazil
Boehringer Ingelheim Investigational Site
Caxias do Sul, Brazil
Boehringer Ingelheim Investigational Site
Curitiba, Brazil
Boehringer Ingelheim Investigational Site
Goiania, Brazil
Boehringer Ingelheim Investigational Site
Maceio, Brazil
Boehringer Ingelheim Investigational Site
Passo Fundo, Brazil
Boehringer Ingelheim Investigational Site
Porto Alegre, Brazil
Boehringer Ingelheim Investigational Site
Recife, Brazil
Boehringer Ingelheim Investigational Site
Rio de Janeiro, Brazil
Boehringer Ingelheim Investigational Site
Salvador, Brazil
Boehringer Ingelheim Investigational Site
Sao Jose do Rio Preto, Brazil
Boehringer Ingelheim Investigational Site
Sao Paulo, Brazil
Boehringer Ingelheim Investigational Site
São Paulo, Brazil
Boehringer Ingelheim Investigational Site
Tatui, Brazil
Boehringer Ingelheim Investigational Site
Votuporanga, Brazil
Canada, Alberta
Boehringer Ingelheim Investigational Site
Calgary, Alberta, Canada
Boehringer Ingelheim Investigational Site
Edmonton, Alberta, Canada
Canada, British Columbia
Boehringer Ingelheim Investigational Site
Coquitlam, British Columbia, Canada
Boehringer Ingelheim Investigational Site
Kelowna, British Columbia, Canada
Boehringer Ingelheim Investigational Site
Richmond, British Columbia, Canada
Boehringer Ingelheim Investigational Site
Surrey, British Columbia, Canada
Boehringer Ingelheim Investigational Site
Victoria, British Columbia, Canada
Canada, New Brunswick
Boehringer Ingelheim Investigational Site
Saint John, New Brunswick, Canada
Canada, Newfoundland and Labrador
Boehringer Ingelheim Investigational Site
St. John's, Newfoundland and Labrador, Canada
Canada, Nova Scotia
Boehringer Ingelheim Investigational Site
Antigonish, Nova Scotia, Canada
Boehringer Ingelheim Investigational Site
Halifax, Nova Scotia, Canada
Canada, Ontario
Boehringer Ingelheim Investigational Site
Cambridge, Ontario, Canada
Boehringer Ingelheim Investigational Site
Grimsby, Ontario, Canada
Boehringer Ingelheim Investigational Site
Hamilton, Ontario, Canada
Boehringer Ingelheim Investigational Site
London, Ontario, Canada
Boehringer Ingelheim Investigational Site
MIssissauga, Ontario, Canada
Boehringer Ingelheim Investigational Site
Newmarket, Ontario, Canada
Boehringer Ingelheim Investigational Site
Oakville, Ontario, Canada
Boehringer Ingelheim Investigational Site
Oshawa, Ontario, Canada
Boehringer Ingelheim Investigational Site
Ottawa, Ontario, Canada
Boehringer Ingelheim Investigational Site
Stoney Creek, Ontario, Canada
Boehringer Ingelheim Investigational Site
Toronto, Ontario, Canada
Canada, Quebec
Boehringer Ingelheim Investigational Site
Chicoutimi, Quebec, Canada
Boehringer Ingelheim Investigational Site
Levis, Quebec, Canada
Boehringer Ingelheim Investigational Site
Montreal, Quebec, Canada
Boehringer Ingelheim Investigational Site
Québec, Quebec, Canada
Boehringer Ingelheim Investigational Site
Sainte-Foy, Quebec, Canada
Boehringer Ingelheim Investigational Site
Sherbrooke, Quebec, Canada
Boehringer Ingelheim Investigational Site
St-Jean-sur-Richel, Quebec, Canada
Canada, Saskatchewan
Boehringer Ingelheim Investigational Site
Saskatoon, Saskatchewan, Canada
Chile
Boehringer Ingelheim Investigational Site
Las Condes, Chile
Boehringer Ingelheim Investigational Site
Santiago, Chile
Boehringer Ingelheim Investigational Site
Temuco, Chile
Boehringer Ingelheim Investigational Site
Vitacura, Chile
Boehringer Ingelheim Investigational Site
Viña del Mar, Chile
China
Boehringer Ingelheim Investigational Site
Beijing, China
Boehringer Ingelheim Investigational Site
Changchun, China
Boehringer Ingelheim Investigational Site
Changsha, China
Boehringer Ingelheim Investigational Site
Chengdu, China
Boehringer Ingelheim Investigational Site
Dalian, China
Boehringer Ingelheim Investigational Site
Foshan, China
Boehringer Ingelheim Investigational Site
Fuzhou, China
Boehringer Ingelheim Investigational Site
Guangzhou, China
Boehringer Ingelheim Investigational Site
Hangzhou, China
Boehringer Ingelheim Investigational Site
Jinan, China
Boehringer Ingelheim Investigational Site
Jining, China
Boehringer Ingelheim Investigational Site
Nanchang, China
Boehringer Ingelheim Investigational Site
Nanjing, China
Boehringer Ingelheim Investigational Site
QingDao, China
Boehringer Ingelheim Investigational Site
Shanghai, China
Boehringer Ingelheim Investigational Site
Shenyang, China
Boehringer Ingelheim Investigational Site
Shenzhen, China
Boehringer Ingelheim Investigational Site
Shijiazhuang, China
Boehringer Ingelheim Investigational Site
Suzhou, China
Boehringer Ingelheim Investigational Site
Tai'an, China
Boehringer Ingelheim Investigational Site
Taiyuan, China
Boehringer Ingelheim Investigational Site
Tianjin, China
Boehringer Ingelheim Investigational Site
Wuhan, China
Boehringer Ingelheim Investigational Site
Xi'An, China
Boehringer Ingelheim Investigational Site
Xiamen, China
Boehringer Ingelheim Investigational Site
Xuzhou, China
Boehringer Ingelheim Investigational Site
Yangzhou, China
Boehringer Ingelheim Investigational Site
Zhengzhou, China
Boehringer Ingelheim Investigational Site
Zoucheng, China
Colombia
Boehringer Ingelheim Investigational Site
Bogota DC, Colombia
Boehringer Ingelheim Investigational Site
Bogota, Colombia
Boehringer Ingelheim Investigational Site
Bogotá, Colombia
Boehringer Ingelheim Investigational Site
Cali -Valle del Cauca, Colombia
Boehringer Ingelheim Investigational Site
Cali, Colombia
Boehringer Ingelheim Investigational Site
Cartagena de Indias, Colombia
Boehringer Ingelheim Investigational Site
Floridablanca, Colombia
Boehringer Ingelheim Investigational Site
Manizales, Colombia
Boehringer Ingelheim Investigational Site
Medellin, Colombia
Boehringer Ingelheim Investigational Site
Quindio, Colombia
Ecuador
Boehringer Ingelheim Investigational Site
Guayaquil, Ecuador
Boehringer Ingelheim Investigational Site
Quito, Ecuador
Hong Kong
Boehringer Ingelheim Investigational Site
Hong Kong, Hong Kong
Japan
Boehringer Ingelheim Investigational Site
Chiba, Asahi, Japan
Boehringer Ingelheim Investigational Site
Chiba, Matsudo, Japan
Boehringer Ingelheim Investigational Site
Ehime, Matsuyama, Japan
Boehringer Ingelheim Investigational Site
Fukui, Fukui, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Fukuoka, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Iizuka, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Itoshima, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Kasuga, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Kitakyushu, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Onga, Japan
Boehringer Ingelheim Investigational Site
Hokkaido, Sapporo, Japan
Boehringer Ingelheim Investigational Site
Hyogo, Kobe, Japan
Boehringer Ingelheim Investigational Site
Hyogo, Takarazuka, Japan
Boehringer Ingelheim Investigational Site
Isikawa, Nomi, Japan
Boehringer Ingelheim Investigational Site
Kagawa , Higashikagawa, Japan
Boehringer Ingelheim Investigational Site
Kagawa , Takamatsu, Japan
Boehringer Ingelheim Investigational Site
Kanagawa, Kawasaki, Japan
Boehringer Ingelheim Investigational Site
Kanagawa, Sagamihara, Japan
Boehringer Ingelheim Investigational Site
Kochi, Kochi, Japan
Boehringer Ingelheim Investigational Site
Kumamoto, Kumamoto, Japan
Boehringer Ingelheim Investigational Site
Kumamoto, Yatsushiro, Japan
Boehringer Ingelheim Investigational Site
Kyoto, Uji, Japan
Boehringer Ingelheim Investigational Site
Nagano, Iida, Japan
Boehringer Ingelheim Investigational Site
Nagano, Suwa, Japan
Boehringer Ingelheim Investigational Site
Niigata, Nagaoka, Japan
Boehringer Ingelheim Investigational Site
Osaka, Daito, Japan
Boehringer Ingelheim Investigational Site
Osaka, Kawachinagano, Japan
Boehringer Ingelheim Investigational Site
Osaka, Matsubara, Japan
Boehringer Ingelheim Investigational Site
Osaka, Osaka, Japan
Boehringer Ingelheim Investigational Site
Osaka, Yao, Japan
Boehringer Ingelheim Investigational Site
Saitama, Okegawa, Japan
Boehringer Ingelheim Investigational Site
Saitama, Tokorozawa, Japan
Boehringer Ingelheim Investigational Site
Shiga, Kusatsu, Japan
Boehringer Ingelheim Investigational Site
Shizuoka, Shizuoka, Japan
Boehringer Ingelheim Investigational Site
Tokyo, Chuo-ku, Japan
Boehringer Ingelheim Investigational Site
Tokyo, Hachioji, Japan
Boehringer Ingelheim Investigational Site
Tokyo, Kodaira, Japan
Boehringer Ingelheim Investigational Site
Tokyo, Minato-ku, Japan
Boehringer Ingelheim Investigational Site
Tokyo, Setagaya, Japan
Boehringer Ingelheim Investigational Site
Toyama, Toyama, Japan
Korea, Republic of
Boehringer Ingelheim Investigational Site
Bucheon, Korea, Republic of
Boehringer Ingelheim Investigational Site
Busan, Korea, Republic of
Boehringer Ingelheim Investigational Site
Daegu, Korea, Republic of
Boehringer Ingelheim Investigational Site
Daejeon, Korea, Republic of
Boehringer Ingelheim Investigational Site
Gwangju, Korea, Republic of
Boehringer Ingelheim Investigational Site
Iksan, Korea, Republic of
Boehringer Ingelheim Investigational Site
Jeju, Korea, Republic of
Boehringer Ingelheim Investigational Site
Jeonju, Korea, Republic of
Boehringer Ingelheim Investigational Site
Jinju, Korea, Republic of
Boehringer Ingelheim Investigational Site
Pusan, Korea, Republic of
Boehringer Ingelheim Investigational Site
Seongnam, Korea, Republic of
Boehringer Ingelheim Investigational Site
Seoul, Korea, Republic of
Boehringer Ingelheim Investigational Site
Suwon, Korea, Republic of
Boehringer Ingelheim Investigational Site
Ulsan, Korea, Republic of
Boehringer Ingelheim Investigational Site
Yangsan, Korea, Republic of
Lebanon
Boehringer Ingelheim Investigational Site
Baabda, Lebanon
Boehringer Ingelheim Investigational Site
Beirut, Lebanon
Boehringer Ingelheim Investigational Site
Byblos, Lebanon
Boehringer Ingelheim Investigational Site
Saida, Lebanon
Mexico
Boehringer Ingelheim Investigational Site
Acapulco de Juárez, Guerrero, Mexico
Boehringer Ingelheim Investigational Site
Aguascalientes, Mexico
Boehringer Ingelheim Investigational Site
Chihuahua, Mexico
Boehringer Ingelheim Investigational Site
Culiacan, Mexico
Boehringer Ingelheim Investigational Site
Distrito Federal, Mexico
Boehringer Ingelheim Investigational Site
Durango, Mexico
Boehringer Ingelheim Investigational Site
Guadalajara, Mexico
Boehringer Ingelheim Investigational Site
Mexico, Mexico
Boehringer Ingelheim Investigational Site
Monterrey, Nuevo Leon, Mexico
Boehringer Ingelheim Investigational Site
Monterrey, Mexico
Boehringer Ingelheim Investigational Site
Monterrrey, Mexico
Boehringer Ingelheim Investigational Site
Morelia, Michoacan, Mexico
Boehringer Ingelheim Investigational Site
Mérida, Yucatán, Mexico
Boehringer Ingelheim Investigational Site
México, Mexico
Boehringer Ingelheim Investigational Site
Orizaba, Mexico
Boehringer Ingelheim Investigational Site
Querétaro, Mexico
Boehringer Ingelheim Investigational Site
San Luis Potosi, Mexico
Boehringer Ingelheim Investigational Site
Tijuana, Mexico
Boehringer Ingelheim Investigational Site
Toluca, Estado de Mexico, Mexico
Peru
Boehringer Ingelheim Investigational Site
Arequipa, Peru
Boehringer Ingelheim Investigational Site
Bellavista, Peru
Boehringer Ingelheim Investigational Site
Callao, Peru
Boehringer Ingelheim Investigational Site
La Victoria, Peru
Boehringer Ingelheim Investigational Site
Lima, Peru
Boehringer Ingelheim Investigational Site
Lince, Peru
Boehringer Ingelheim Investigational Site
San Borja, Peru
Boehringer Ingelheim Investigational Site
San Isidro, Peru
Boehringer Ingelheim Investigational Site
San Martin de Porres, Peru
Russian Federation
Boehringer Ingelheim Investigational Site
Barnaul, Russian Federation
Boehringer Ingelheim Investigational Site
Chelyabinsk, Russian Federation
Boehringer Ingelheim Investigational Site
Chita, Russian Federation
Boehringer Ingelheim Investigational Site
Dzerjinskiy, Russian Federation
Boehringer Ingelheim Investigational Site
Ekaterinburg, Russian Federation
Boehringer Ingelheim Investigational Site
Irkutsk, Russian Federation
Boehringer Ingelheim Investigational Site
Izhevsk, Russian Federation
Boehringer Ingelheim Investigational Site
Kemerovo, Russian Federation
Boehringer Ingelheim Investigational Site
Krasnodar, Russian Federation
Boehringer Ingelheim Investigational Site
Krasnoyarsk, Russian Federation
Boehringer Ingelheim Investigational Site
Moscow, Russian Federation
Boehringer Ingelheim Investigational Site
Novosibirsk, Russian Federation
Boehringer Ingelheim Investigational Site
Omsk, Russian Federation
Boehringer Ingelheim Investigational Site
Orenburg, Russian Federation
Boehringer Ingelheim Investigational Site
Perm, Russian Federation
Boehringer Ingelheim Investigational Site
Rostov-on-Don, Russian Federation
Boehringer Ingelheim Investigational Site
Ryazan, Russian Federation
Boehringer Ingelheim Investigational Site
Samara, Russian Federation
Boehringer Ingelheim Investigational Site
Saratov, Russian Federation
Boehringer Ingelheim Investigational Site
St. Petersburg, Russian Federation
Boehringer Ingelheim Investigational Site
Vladivostok, Russian Federation
Saudi Arabia
Boehringer Ingelheim Investigational Site
Dammam, Saudi Arabia
Boehringer Ingelheim Investigational Site
Hufuf, Saudi Arabia
Boehringer Ingelheim Investigational Site
Jeddah, Saudi Arabia
Boehringer Ingelheim Investigational Site
Riyadh, Saudi Arabia
Boehringer Ingelheim Investigational Site
Tabuk, Saudi Arabia
Boehringer Ingelheim Investigational Site
Taif, Saudi Arabia
Singapore
Boehringer Ingelheim Investigational Site
Singapore, Singapore
South Africa
Boehringer Ingelheim Investigational Site
Durban, South Africa
Boehringer Ingelheim Investigational Site
Johannesburg, South Africa
Boehringer Ingelheim Investigational Site
Somerset West, Cape Town, South Africa
Boehringer Ingelheim Investigational Site
Tongaat, South Africa
Taiwan
Boehringer Ingelheim Investigational Site
Kaohsiung, Taiwan
Boehringer Ingelheim Investigational Site
Taichung, Taiwan
Boehringer Ingelheim Investigational Site
Tainan, Taiwan
Boehringer Ingelheim Investigational Site
Taipei, Taiwan
Boehringer Ingelheim Investigational Site
Taoyuan, Taiwan
United Arab Emirates
Boehringer Ingelheim Investigational Site
Abu Dhabi, United Arab Emirates
Boehringer Ingelheim Investigational Site
Dubai, United Arab Emirates
Boehringer Ingelheim Investigational Site
Sharjah, United Arab Emirates
Venezuela
Boehringer Ingelheim Investigational Site
San Roman Caracas, Venezuela
Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Boehringer Ingelheim
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Boehringer Ingelheim
ClinicalTrials.gov Identifier: NCT01468701     History of Changes
Other Study ID Numbers: 1160.129
Study First Received: October 28, 2011
Last Updated: March 27, 2017

Additional relevant MeSH terms:
Atrial Fibrillation
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on June 27, 2017